Last updated on April 2019

Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC

Brief description of study

This study determine the maximal tolerate dose

Detailed Study Description

This study determine the maximal tolerate dose for the patient treated by intraperitoneal chemotherapy in neoadjuvant treatment of peritoneal carcinomatosis of colorectal origin

Clinical Study Identifier: NCT03253133

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.